Description
Tripterygium wilfordii, a perennial twining shrub of the Celastrales, has been used medicinally for centuries, mainly to treat rheumatoid arthritis. triptolide has been demonstrated to possess important therapeutic potential with anti-inflammatory, immunosuppressive, and antitumor activities, as well as to exhibit potentially medically relevant activity for central nervous system diseases.
- SUMMARY
-
Published journals
Nature Communications
-
Publish date
2020.02
-
Sequence Method
Illumina HiSeq, PacBio
-
Assembly
ASM1340144v1
-
Assembly Method
FALCON v. 3.1
-
Genome Size
348.533 Mb
-
Genome Coverage
793.34x
-
Scaffolds
321
-
Contigs
467
-
N50
4362171
-
GC%
37.58
-
Bioproject
PRJNA542587
-
GCA Number
GCA_013401445.1
-
Data
https://ftp.ncbi.nlm.nih.gov/genomes/all/GCA/013/401/445/GCA_013401445.1_ASM1340144v1/
-
Reference url
Reference
Tu, L., Su, P., Zhang, Z., Gao, L., Wang, J., Hu, T., Zhou, J., Zhang, Y., Zhao, Y., Liu, Y., Song, Y., Tong, Y., Lu, Y., Yang, J., Xu, C., Jia, M., Peters, R. J., Huang, L., & Gao, W. (2020). Genome of Tripterygium wilfordii and identification of cytochrome P450 involved in triptolide biosynthesis. Nature communications, 11(1), 971.